We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+13.77%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.41B
AUM Growth
-$838M
Cap. Flow
-$1.23B
Cap. Flow %
-19.2%
Top 10 Hldgs %
13.63%
Holding
1,903
New
444
Increased
263
Reduced
318
Closed
672

Top Sells

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$43.9M
2
UAN icon
CVR Partners
UAN
+$26M
3
ZM icon
Zoom
ZM
+$12.1M
4
EQT icon
EQT Corp
EQT
+$12M
5
PING
Ping Identity Holding Corp.
PING
+$6.13M

Sector Composition

Rank Sector Weight
1 Healthcare 2.55%
2 Energy 1.26%
3 Technology 1.15%
4 Consumer Discretionary 0.9%
5 Materials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTIC
876
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$610K 0.01%
+101,500
New +$554K
UPLD icon
877
CALL
Upland Software
UPLD
$12.9M
$606K 0.01%
+8,500
New +$634K
OEC icon
878
PUT
Orion
OEC
$383M
$606K 0.01%
+34,000
New +$572K
AIV
879
Aimco
AIV
$388M
$603K 0.01%
84,688
CBAY
880
CALL
DELISTED
Cymabay Therapeutics
CBAY
$596K 0.01%
95,000
+45,000
+90% +$171K
CBAY
881
PUT
DELISTED
Cymabay Therapeutics
CBAY
$596K 0.01%
95,000
+45,000
+90% +$171K
KMX icon
882
CarMax
KMX
$8.25B
$596K 0.01%
+9,780
New +$628K
P
883
PUT
Everpure Inc
P
$26.3B
$594K 0.01%
+22,200
New +$646K
AGX icon
884
Argan
AGX
$8.17B
$594K 0.01%
16,100
PDBC icon
885
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.29B
$591K 0.01%
40,000
-287,500
-88% -$4.79M
PLNT icon
886
Planet Fitness
PLNT
$4.47B
$591K 0.01%
+7,500
New +$523K
BEEM icon
887
Beam Global
BEEM
$24M
$588K 0.01%
+33,678
New +$504K
GTLS
888
DELISTED
Chart Industries
GTLS
$576K 0.01%
+5,000
New +$803K
MGM icon
889
CALL
MGM Resorts International
MGM
$11.4B
$573K 0.01%
17,100
-226,900
-93% -$7.86M
GDX icon
890
VanEck Gold Miners ETF
GDX
$22.9B
$573K 0.01%
+20,000
New +$535K
EVH icon
891
Evolent Health
EVH
$366M
$570K 0.01%
+20,313
New +$582K
SE icon
892
Sea Limited
SE
$67.4B
$564K 0.01%
10,843
+10,643
+5,322% +$574K
PR
893
CALL
Permian Resources
PR
$17.6B
$564K 0.01%
60,000
ADT icon
894
ADT
ADT
$5.72B
$563K 0.01%
+62,100
New +$552K
CNK icon
895
CALL
Cinemark Holdings
CNK
$4.42B
$563K 0.01%
+65,000
New +$732K
FUN icon
896
Cedar Fair
FUN
$1.82B
$562K 0.01%
13,600
-1,200
-8% -$48.2K
TBPH icon
897
PUT
Theravance Biopharma
TBPH
$874M
$561K 0.01%
50,000
-10,000
-17% -$105K
PINC
898
DELISTED
Premier
PINC
$560K 0.01%
+16,016
New +$534K
SI
899
DELISTED
Silvergate Capital Corporation
SI
$559K 0.01%
+32,100
New +$1.27M
ALLT icon
900
Allot
ALLT
$381M
$556K 0.01%
+161,730
New +$607K

Similar funds

Caption Management's Q4 2022 Portfolio in Review

As of Q4 2022, Caption Management held 1,903 positions worth $6.41B, down 12% from $7.25B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management withdrew a net $1.23B in Q4 2022, closing 672 positions and reducing 318 holdings. Its most notable exit was Petrobras, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.5% a quarter earlier, followed by Energy and Technology.

Against the trend, Caption Management opened a new position in PennyMac Mortgage Investment worth $17.9M.

  • Caption Management's largest Q4 2022 buy was PennyMac Mortgage Investment: 1,448,050 shares worth $17.9M.
  • Caption Management added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $13.6M increase.
  • Caption Management's biggest Q4 2022 reduction was EQT Corp, cutting an estimated $12M.
  • Caption Management fully exited Petrobras in Q4 2022, selling an estimated $43.9M.
  • Caption Management's ten largest holdings make up 14% of its $6.41B portfolio in Q4 2022.
  • Caption Management opened 444 new positions and closed 672 in Q4 2022.
  • Caption Management's portfolio value fell 12% quarter-over-quarter to $6.41B.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.